Advanced Filters
noise

rett-syndrome Clinical Trials

A listing of rett-syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 17 clinical trials
D Daniela Tropea

Biomarkers in Rett Syndrome

Rett syndrome (RTT) is an X-linked genetic disorder that causes severe neurological development disorder. In its classic form, it seems to affect almost exclusively females with an incidence of up to one in 10,000 females. Patients affected by Rett Syndrome can present a wide range of symptoms, in different combinations …

- 18 years of age Female Phase N/A
H Holly Dubbs

Neurophysiologic Biomarkers in Rett Syndrome

The goal of this observational study is to identify candidate biomarkers in individuals with Rett Syndrome (RTT). The main questions it aims to answer are: Do these biomarkers change during clinical changes in individuals with RTT? Are biomarkers stable over time in clinically stable individuals? Do these biomarkers correlate with …

1 - 18 years of age Female Phase N/A
N Natalia Klamut

The Diagnostic Experience of Male Rett Syndrome

The Diagnostic Experience of Male Rett Syndrome collects information on the lived experiences of parents or caregivers to boys with Rett Syndrome. Key information examined includes the process of getting a male Rett syndrome diagnosis, your son's systems of care, and your priorities for his health needs. Enrolled participants will …

- 100 years of age Male Phase N/A

Cognitive Function in Rett Syndrome During Trofinetide Treatment

Assessing cognitive functions among individuals with severe intellectual and developmental disabilities (IDD), including RTT, is often challenging due to floor effects of many standardized assessment batteries in this population. In addition, deficits in motor function and verbal ability may obscure certain abilities in this population when using standard IQ measures. …

18 - 99 years of age All Phase N/A
I Ilaria Meloni, BS.PhD

Gene Editing as a Therapeutic Approach for Rett Syndrome

We designed the project to validate CRISPR/Cas9-based gene editing combined with AAV-based delivery for correction of the most common MECP2 mutations both in vitro and in vivo.

6 years of age Female Phase N/A
S Shelley Coughlin

Validating Innovative Biosensors for Rett Autonomic Symptom Tracking

The VIBRANT study aims to validate biosensors to objectively and directly measure symptoms in Rett syndrome and create confidence in the use of these devices in clinical trials. VIBRANT will use several FDA-cleared wearable biosensors and a non-wearable device to collect symptom data from patients with Rett syndrome for up …

years of age All Phase N/A
B Bashar A Abdulhassan, Assistant professor of surgery

Comparison of RTS and MGAP Scores in Predicting Outcomes of Trauma Patients

The goal of this prospective cohort study is to compare the predictive accuracy of the Revised Trauma Score (RTS) and the MGAP score in determining clinical outcomes among multiple trauma patients hospitalized at a trauma center in Iraq. The main questions it aims to answer are: Which score, RTS or …

18 years of age All Phase N/A

Simplify language using AI